Search
for
Sort by
Research 571–600 of 780
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- Oxidative stress and alopecia areata
- The genetic basis of dermatophytosis skin infection susceptibility
- NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- 600 Impact of baricitinib on work productivity and indirect costs in adult patients with atopic dermatitis: A meta-analysis of clinical trials
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Surgical Approaches for Repigmenting Vitiligo 2.0
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata